Insider Selling: Halozyme Therapeutics (NASDAQ:HALO) CEO Sells 20,000 Shares of Company Stock
Halozyme Therapeutics, Inc. (NASDAQ:HALO – Get Free Report) CEO Helen Torley sold 20,000 shares of the business’s stock in a transaction on Monday, November 16th. The shares were sold at an average price of $98.38, for a total transaction of $1,967,600.00. Following the sale, the chief executive officer owned 767,780 shares of the company’s stock, […]
17 Nov 02:09 · The Markets Daily